Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Applying to NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center · New York, New York
Answer a few short questions to share with the research team.